PortfoliosLab logoPortfoliosLab logo
HRMY vs. MNDY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HRMY vs. MNDY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harmony Biosciences Holdings, Inc. (HRMY) and monday.com Ltd. (MNDY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HRMY achieves a -14.22% return, which is significantly higher than MNDY's -41.75% return.


HRMY

1D
3.85%
1M
-1.50%
YTD
-14.22%
6M
-13.24%
1Y
-9.09%
3Y*
-3.02%
5Y*
-0.67%
10Y*

MNDY

1D
-6.08%
1M
11.16%
YTD
-41.75%
6M
-43.65%
1Y
-72.04%
3Y*
-21.10%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HRMY vs. MNDY - Yearly Performance Comparison


2026 (YTD)20252024202320222021
HRMY
Harmony Biosciences Holdings, Inc.
-14.22%8.75%6.53%-41.38%29.22%30.64%
MNDY
monday.com Ltd.
-41.75%-37.33%25.36%53.94%-60.48%72.59%

Correlation

The correlation between HRMY and MNDY is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Jun 11, 2021

0.23

Fundamentals

Market Cap

HRMY:

$1.89B

MNDY:

$4.20B

EPS

HRMY:

$2.48

MNDY:

$2.29

PE Ratio

HRMY:

12.93

MNDY:

37.51

PEG Ratio

HRMY:

0.13

MNDY:

0.15

PS Ratio

HRMY:

2.09

MNDY:

3.44

PB Ratio

HRMY:

2.07

MNDY:

5.53

Total Revenue (TTM)

HRMY:

$899.11M

MNDY:

$1.30B

Gross Profit (TTM)

HRMY:

$688.25M

MNDY:

$1.16B

EBITDA (TTM)

HRMY:

$221.74M

MNDY:

$62.24M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HRMY vs. MNDY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRMY
HRMY Risk / Return Rank: 3131
Overall Rank
HRMY Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
HRMY Sortino Ratio Rank: 2929
Sortino Ratio Rank
HRMY Omega Ratio Rank: 2929
Omega Ratio Rank
HRMY Calmar Ratio Rank: 3131
Calmar Ratio Rank
HRMY Martin Ratio Rank: 3232
Martin Ratio Rank

MNDY
MNDY Risk / Return Rank: 55
Overall Rank
MNDY Sharpe Ratio Rank: 33
Sharpe Ratio Rank
MNDY Sortino Ratio Rank: 33
Sortino Ratio Rank
MNDY Omega Ratio Rank: 22
Omega Ratio Rank
MNDY Calmar Ratio Rank: 66
Calmar Ratio Rank
MNDY Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRMY vs. MNDY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and monday.com Ltd. (MNDY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HRMYMNDYDifference
Sharpe ratioReturn per unit of total volatility

+0.88

Sortino ratioReturn per unit of downside risk

+1.91

Omega ratioGain probability vs. loss probability

1.00

0.74

+0.26

Calmar ratioReturn relative to maximum drawdown

-0.26

-0.89

+0.62

Martin ratioReturn relative to average drawdown

-0.49

-1.31

+0.82

HRMY vs. MNDY - Sharpe Ratio Comparison

The current HRMY Sharpe Ratio is -0.22, which is higher than the MNDY Sharpe Ratio of -1.10. The chart below compares the historical Sharpe Ratios of HRMY and MNDY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HRMYMNDYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.22

-1.10

+0.88

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.05

-0.19

+0.14

Drawdowns

HRMY vs. MNDY - Drawdown Comparison

The maximum HRMY drawdown since its inception was -68.48%, smaller than the maximum MNDY drawdown of -86.78%. Use the drawdown chart below to compare losses from any high point for HRMY and MNDY.


Loading charts...

Drawdown Indicators


HRMYMNDYDifference

Max Drawdown

Largest peak-to-trough decline

-68.48%

-86.78%

+18.30%

Max Drawdown (1Y)

Largest decline over 1 year

-34.49%

-81.30%

+46.81%

Max Drawdown (3Y)

Largest decline over 3 years

-50.81%

-82.07%

+31.26%

Max Drawdown (5Y)

Largest decline over 5 years

-68.48%

Current Drawdown

Current decline from peak

-47.30%

-80.67%

+33.37%

Average Drawdown

Average peak-to-trough decline

-35.20%

-54.19%

+18.99%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.69%

55.05%

-36.36%

Volatility

HRMY vs. MNDY - Volatility Comparison

The current volatility for Harmony Biosciences Holdings, Inc. (HRMY) is 10.05%, while monday.com Ltd. (MNDY) has a volatility of 24.83%. This indicates that HRMY experiences smaller price fluctuations and is considered to be less risky than MNDY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HRMYMNDYDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.05%

24.83%

-14.78%

Volatility (6M)

Calculated over the trailing 6-month period

30.17%

49.25%

-19.08%

Volatility (1Y)

Calculated over the trailing 1-year period

41.40%

65.39%

-23.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.04%

72.02%

-21.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

52.40%

72.02%

-19.62%

Dividends

HRMY vs. MNDY - Dividend Comparison

Neither HRMY nor MNDY has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

HRMY vs. MNDY - Financials Comparison

This section allows you to compare key financial metrics between Harmony Biosciences Holdings, Inc. and monday.com Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
215.39M
351.27M
(HRMY) Total Revenue
(MNDY) Total Revenue
Values in USD except per share items

HRMY vs. MNDY - Profitability Comparison

The chart below illustrates the profitability comparison between Harmony Biosciences Holdings, Inc. and monday.com Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

70.0%75.0%80.0%85.0%90.0%20222023202420252026
79.3%
89.2%
Portfolio components
HRMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a gross profit of 170.88M and revenue of 215.39M. Therefore, the gross margin over that period was 79.3%.

MNDY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, monday.com Ltd. reported a gross profit of 313.14M and revenue of 351.27M. Therefore, the gross margin over that period was 89.2%.

HRMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported an operating income of 37.29M and revenue of 215.39M, resulting in an operating margin of 17.3%.

MNDY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, monday.com Ltd. reported an operating income of 19.75M and revenue of 351.27M, resulting in an operating margin of 5.6%.

HRMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a net income of 32.49M and revenue of 215.39M, resulting in a net margin of 15.1%.

MNDY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, monday.com Ltd. reported a net income of 28.03M and revenue of 351.27M, resulting in a net margin of 8.0%.


Frequently Asked Questions


HRMY and MNDY have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MNDY has higher volatility (24.83%) compared to HRMY (10.05%). In terms of maximum drawdown, HRMY dropped -68.48% vs MNDY's -86.78%.

HRMY currently has the higher Sharpe Ratio (-0.22 vs -1.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HRMY and MNDY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer